Vaxcyte, Inc.

$106.67 3.87%
NASDAQ: PCVX
Market Cap.: 13.0 B L
P/E: -23.19 x3.3
EPS: -4.60 x 5.9
Earnings Call
3 months, 2 weeks from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 965,687
871,967 Moderate Low
Performance Ranks (Intraday)
United States:

105th

out of

2160

Healthcare:

58th

out of

792

Biotechnology:

26th

out of

227

Peer Group:

1st

out of

6

About

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 …